Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Amicus, BMS, Brooklyn Immunotherapeutics, Cardior, Curis, Cyclo, Evolve, Exelixis, Heat, Innate, Innovent, Ipsen, Janssen, Kalvista, Medigene, Melt, Neurorx, Opiant, Orchard, Paxmedica, Regenxbio, Sumitomo, Taiga, Trefoil, Turn.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AC Immune, Avrobio, Cassava, Covaxx, Cue, Dong-A, Eiger, Erytech, Freeline, Jasper, Magenta, Sinovac, Uniqure, Veru.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achilles, Astrazeneca, Covaxx, GSK, I-Mab, PTC, Sanofi, Spark, Spero.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Daxor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Agenus, Aldeyra, Aligos, Atea, Biogen, Botanix, Calliditas, Codiak, Corvus, Crinetics, Curevac, Dynavax, Eucure, Gilead, Golden, I-Mab, Innocare, Neurorx, Reistone, Surface Ophthalmology.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arquer Diagnostics, Diadem, Nēsos.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Bioarctic, Biophytis, Covaxx, Crinetics, Daiichi, Eisai, Enlivex, Gemoab, Imcyse, LB, PDS, Revelation, Sio, Vaxart, Vectivbio, Viacyte.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Appili, Astrazeneca, Beigene, Daiichi Sankyo, Dimerix, Dr. Reddy’s, Dynavax, Eli Lilly, Eucure Beijing, Glaxosmithkline, Humanigen, I-Mab, Immutep, Innovation, Johnson & Johnson, Lead Discovery Center, Morphosys, Novavax, Oncosec Medical, Qurient, Redhill, Regeneron, Sichuan Clover, Sorrento, Takeda, Valneva, VBL, Vicore, Vir.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abpro, Arch, Arena, Biomx, BMS, Bridgebio, Calcimedica, Cassava, Chemomab, Curis, Daiichi, Diurnal, Exonate, Gedea, Gemini, Immunovant, Janssen, Kira, Pharnext, Pinteon, RDIF, Secura, Selva, Tiziana, Travere, Verona.